EUVIMEDUpptäck EUVIMED
Übersichtsarbeit

Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization

Qichao Hu iD, Wenwen Zhang, Feng Wei iD, Meilan Huang, Mengyao Shu, Dan Song, Jianxia Wen iD, Jundong Wang, Qing Nian, Xiao Ma iD, Jinhao Zeng iD, Yanling Zhao

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8043 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, 2024. Written by Qichao Hu and 11 co-authors. Institution: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Chi…. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular, Liver Neoplasms. Cited 22 times so far (Crossref); 240 references.

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

This review focuses on the potential ameliorative effects of polyphenolic compounds derived from human diet on hepatic diseases. It discusses the molecular mechanisms and recent advancements in clinical applications. Edible polyphenols have been found to play a therapeutic role, particularly in liver injury, liver fibrosis, NAFLD/NASH, and HCC. In the regulation of liver injury, polyphenols exhibit anti‐inflammatory and antioxidant effects, primarily targeting the TGF‐β, NF‐κB/TLR4, PI3K/AKT, and Nrf2/HO‐1 signaling pathways. In the regulation of liver fibrosis, polyphenolic compounds effectively reverse the fibrotic process by inhibiting the activation of hepatic stellate cells (HSC). Furthermore, polyphenolic compounds show efficacy against NAFLD/NASH by inhibiting lipid oxidation and accumulation, mediated through the AMPK, SIRT, and PPARγ pathways. Moreover, several polyphenolic compounds exhibit anti‐HCC activity by suppressing tumor cell proliferation and metastasis. This inhibition primarily involves blocking Akt and Wnt signaling, as well as inhibiting the epithelial‐mesenchymal transition (EMT). Additionally, clinical trials and nutritional evidence support the notion that certain polyphenols can improve liver disease and associated metabolic disorders. However, further fundamental research and clinical trials are warranted to validate the efficacy of dietary polyphenols.

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseaseCarcinoma, HepatocellularLiver NeoplasmsHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesLiver CirrhosisLiverWnt Signaling PathwayDiet

Author keywords

NAFLDhepatocellular carcinomaliver fibrosispolyphenolic compound

Substances

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Authors and institutions

  • State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Pharmacy, Chinese PLA General Hospital, Beijing, China.
  • School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • School of Food and Bioengineering, Xihua University, Chengdu, China.
  • Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

ORCID profiles: Qichao Hu, Feng Wei, Jianxia Wen, Xiao Ma, Jinhao Zeng

Cite

APA

Hu, Q., Zhang, W., Wei, F., Huang, M., Shu, M., Song, D., Wen, J., Wang, J., Nian, Q., Ma, X., Zeng, J., & Zhao, Y. (2024). Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization. Phytotherapy Research. https://doi.org/10.1002/ptr.8043

Vancouver

Hu Q, Zhang W, Wei F, Huang M, Shu M, Song D, et al. Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization. Phytotherapy Research. 2024. doi:10.1002/ptr.8043

BibTeX
@article{Hu2024,
  author = {Hu, Qichao and Zhang, Wenwen and Wei, Feng and Huang, Meilan and Shu, Mengyao and Song, Dan and Wen, Jianxia and Wang, Jundong and Nian, Qing and Ma, Xiao and Zeng, Jinhao and Zhao, Yanling},
  title = {Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8043}
}
Start for free →